1. Home
  2. VBNK vs NVCT Comparison

VBNK vs NVCT Comparison

Compare VBNK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VersaBank

VBNK

VersaBank

SELL

Current Price

$24.42

Market Cap

714.4M

Sector

Finance

ML Signal

SELL

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

N/A

Current Price

$19.97

Market Cap

672.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VBNK
NVCT
Founded
1980
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.4M
672.1M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
VBNK
NVCT
Price
$24.42
$19.97
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$27.50
★ $35.40
AVG Volume (30 Days)
78.3K
★ 182.4K
Earning Date
01-07-2027
11-04-2026
Dividend Yield
★ 0.30%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$25.02
N/A
Revenue Next Year
$37.94
N/A
P/E Ratio
$25.91
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.31
$5.77
52 Week High
$25.00
$29.28

Technical Indicators

Market Signals
Indicator
VBNK
NVCT
Relative Strength Index (RSI) 61.81 50.16
Support Level $21.53 $19.78
Resistance Level N/A $22.49
Average True Range (ATR) 0.87 1.54
MACD 0.15 0.08
Stochastic Oscillator 83.24 55.13

Price Performance

Historical Comparison
VBNK
NVCT

About VBNK VersaBank

VersaBank is a Schedule I Canadian bank that provides mainly commercial lending and banking services to select niche markets in Canada and the United States. Its products and services include credit assets, deposits, and cybersecurity services through its wholly owned subsidiary. The bank operates through four segments: Digital Banking Canada and Digital Banking USA, both using a business-to-business model with proprietary financial technology to serve underserved markets; DRTC, which provides cybersecurity services and banking and financial technology development; and Digital Meteor, which owns proprietary technology supporting next-generation digital assets, including Real Bank Deposit Tokens (RBDTs). The majority of revenue comes from Digital Banking.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: